Urine Protease and Antiprotease Activity in Experimental Aminonucleoside Nephrotoxicity
作者:
Michael Mayer,
Saul Yedgar,
Mark Joffe,
Eleazar Shafrir,
期刊:
Nephron
(Karger Available online 1981)
卷期:
Volume 29,
issue 5-6
页码: 223-228
ISSN:1660-8151
年代: 1981
DOI:10.1159/000182376
出版商: S. Karger AG
关键词: Aminonucleoside;Urinary protease;Protease inhibitor;Nephrotoxicity
数据来源: Karger
摘要:
Induction of nephrosis in rats with aminonucleoside of puromycin (ANP) was followed by an increase in urinary protease activity, measured by the cleavage of 14C-globin, as well as in antiprotease activity measured by trypsin inhibition. The excretion of protease and protease inhibitor coincided with but did not precede the onset of proteinuria when the ANP was injected subcutaneously for 5 days and lagged after the proteinuria when the ANP was given as a single intravenous dose. Serum protease activity did not change throughout ANP treatment or later, whereas serum antiprotease capacity declined coincidently with proteinuria, most probably due to the loss in urine. Kidney proteolytic activity was markedly reduced in ANP nephrosis. Treatment of rats with proteolysis inhibitors, trasylol, ε-aminocaproic acid, soybean trypsin inhibitor, or hexapron, together with ANP failed to prevent, delay or reduce the proteinuria. We believe that the urinary protease in ANP nephrosis does not originate from the circulation but from the release of kidney protease as a consequence of the glomerular lesion, and does not appear to be involved in its causation.
点击下载:
PDF
(1076KB)
返 回